Related content

Comment on: Evans JMM, Ogston SA, Emslie-Smith A, Morris AD (2006) Risk of mortality and adverse cardiovascular outcomes in type 2 diabetes: a comparison of patients treated with sulfonylureas and metformin. Diabetologia 49:930–936

By Raccah D.  

Diabetologia, Vol. 50, Iss. 5, 2007-05 ,pp. : 1109-1110

Springer Publishing Company

Access to resources Recommend Favorite

Response to comment on: Evans JMM, Ogston SA, Emslie-Smith A, Morris AD (2006) Risk of mortality and adverse cardiovascular outcomes in type 2 diabetes: a comparison of patients treated with sulphonylureas and metformin. Diabetologia 49:930–936

By Evans J.   Morris A.  

Diabetologia, Vol. 50, Iss. 5, 2007-05 ,pp. : 1111-1111

Springer Publishing Company

Access to resources Recommend Favorite

Comment on: Evans JM, Ogston SA, Emslie-Smith A, Morris A (2006) Risk of mortality and adverse cardiovascular outcomes in type 2 diabetes: a comparison of patients treated with sulfonylureas and metformin. Diabetologia 49:930–936

By Johnson J.   Simpson S.   Eurich D.   Majumdar S.  

Diabetologia, Vol. 49, Iss. 11, 2006-11 ,pp. : 2805-2806

Springer Publishing Company

Access to resources Recommend Favorite

Comment on: Schmidt MI, Duncan BB, Vigo A et al. (2006) Leptin and incident type 2 diabetes: risk or protection? Diabetologia 49:2086–2096

By Arch J.  

Diabetologia, Vol. 50, Iss. 1, 2007-01 ,pp. : 239-240

Springer Publishing Company

Access to resources Recommend Favorite

Response to comment on: Schmidt MI, Duncan BB, Vigo A et al. (2006) Leptin and incident type 2 diabetes: risk or protection? Diabetologia 49:2086–2096

By Schmidt M.   Duncan B.   Vigo A.   Pankow J.   Couper D.   Ballantyne C.   Hoogeveen R.   Heiss G.  

Diabetologia, Vol. 50, Iss. 1, 2007-01 ,pp. : 237-238

Springer Publishing Company

Access to resources Recommend Favorite